Adamas Pharmaceuticals is a biopharmaceutical company focused on developing and commercializing innovative therapies for neurological diseases. Their primary goal is to improve the lives of patients suffering from conditions like Parkinson's disease and multiple sclerosis through targeted treatments that address unmet medical needs. The company is known for its unique approach to drug formulation, which enhances the effectiveness of existing medications. By utilizing advanced technologies, Adamas aims to create products that provide better patient outcomes and improve adherence to treatment regimens, ultimately contributing to the overall management of chronic neurological disorders.